首页 | 本学科首页   官方微博 | 高级检索  
检索        

GLUT-1和DNA-PKcs在卵巢浆液性肿瘤组织中的表达及其意义
作者姓名:Cai Y  Shao SL  Wang QH  Yan LJ  Wang XY  Wang LX
作者单位:1. 首都医科大学附属北京同仁医院南区妇产科,北京,100176
2. 山西省肿瘤医院妇科,山西,太原,030013
3. 山西省肿瘤医院病理科,山西,太原,030013
摘    要:背景与目的:已知肿瘤细胞生长所需能量是通过葡萄糖转运体蛋白1(glucose transporter protein 1,GLUT-1)完成的葡萄糖代谢来提供的.另外,参与基因损伤修复的催化亚单位--DNA蛋白激酶(DNA-dependent protein kinase catalytic subunit,DNA-PKcs)在肿瘤形成中也起着非常重要的作用.本研究旨在探讨GLUT-1和DNA-PKcs在卵巢浆液性肿瘤组织中的表达及其与肿瘤生物学行为的关系和意义.方法:免疫组化方法检测80例卵巢浆液性肿瘤组织中GLUT-1、DNA-PKcs的表达,分析其异常表达与临床病理参数之间的相关性.以正常卵巢组织20例为对照.结果:正常卵巢组织GLUT-1表达全阴性,DNA-PKcs表达全阳性.GLUT-1在良性、交界性、恶性卵巢浆液性肿瘤中的表达呈增高的趋势,与卵巢浆液性肿瘤的发生发展呈正相关(rs=0.943,P<0.01);在恶性肿瘤中的阳性率(100%)明显高于交界性(55%).DNA-PKcs在良性、交界性和恶性卵巢浆液性肿瘤中的阳性率分别为95%、90%、60%,差异有统计学意义(P<0.01).GLUT-1与DNA-PKcs的表达呈负相关(rs=-0.270,P<0.01).GLUT-1表达与临床分期、腹腔种植、腹水、淋巴结转移均相关(P<0.05);DNA-PKcs仅与临床分期和淋巴结转移相关(P<0.05),与腹水、腹腔种植无关(P>0.05).结论:GLUT-1的异常表达和DNA-PKcs的丢失与卵巢浆液性肿瘤恶变相关.

关 键 词:卵巢肿瘤  免疫组化  葡萄糖转运体1  依赖DNA蛋白激酶的催化亚单位
文章编号:1000-467X(2007)11-1188-06
修稿时间:2006-06-26

Expression and significance of GLUT-1 and DNA-PKcs in serous ovarian tumors
Cai Y,Shao SL,Wang QH,Yan LJ,Wang XY,Wang LX.Expression and significance of GLUT-1 and DNA-PKcs in serous ovarian tumors[J].Chinese Journal of Cancer,2007,26(11):1188-1193.
Authors:Cai Yu  Shao Shu-Li  Wang Quan-Hong  Yan Li-Juan  Wang Xiao-Yan  Wang Li-Xia
Institution:1. Department of Gynecology and Obstetrics, Beijing Tongren Hospital, Capital Medical University, Beijing 100176, P. R. China ;2. Department of Gynecology, Shanxi Provincial Cancer Hospital, Taiyuan , Shanxi, 030013, P. R. China; 3. Department of Pathology, Shanxi Provincial Cancer Hospital, Taiyuan, Shanxi, 030013, P. R. China
Abstract:BACKGROUND & OBJECTIVE: Cancer cell growth is supported by glucose metabolism of glucose transporter protein 1 (GLUT-1). In addition, the participation of DNA-dependent protein kinase catalytic subunit (DNA-PKcs) in genome damage-repairing is important for oncogenesis prevention. This study was to evaluate the expression and biologic significance of GLUT-1 and DNA-PKcs in serous ovarian tumors. METHODS: The expression of GLUT-1 and DNA-PKcs in 20 specimens of normal ovarian tissues, 20 specimens of serous cystadenoma, 20 specimens of borderline serous cystadenoma, and 40 specimens of serous cystadenocarcinoma were detected by SP immunohistochemistry. The correlation of GLUT-1 and DNA-Pkcs expression to clinicopathologic characteristics of serous ovarian tumors was analyzed by Chi-square test. RESULTS: The positive rate of GLUT-1 was significantly higher in malignant and borderline serous ovarian carcinomas than in benign tumors and normal ovarian tissues (100% and 55% vs. 0% and 0%, P<0.01). The differences in the positive rate of DNA-PKcs were significant among normal ovarian tissues, benign, borderline, and malignant serous ovarian tumors (100%, 95%, 90%, and 60%, P<0.01). GLUT-1 expression was negatively correlated to DNA-PKcs expression (rs = -0.270, P<0.01). GLUT-1 expression in borderline and malignant serous ovarian tumors was related to intraperitoneal implants, ascites, lymph node metastasis, and FIGO stage, but DNA-PKcs was only related to FIGO stage and lymph node metastasis (P<0.05). CONCLUSION: The expression of GLUT-1 and the loss of DNA-PKcs may be closely related to the malignant transformation of serous ovarian tumors.
Keywords:Ovarian neoplasms  Immunohistochemistry  Glucose transporter 1  DNA-dependent protein kinase catalytic subunit
本文献已被 维普 万方数据 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号